Global Autoimmune Disease Diagnostics Market: Snapshot
The global autoimmune disease diagnostics market is expected to witness a modest growth in the coming years on account of the growing incidences of autoimmune diseases among people worldwide. Efficient autoimmune disease diagnostics has become absolutely essential to tackle this issue. Governments across nations are also increasing their spending towards healthcare in light of these growing incidences of autoimmune diseases. This has also resulted in the research and development of novel diagnostics in order to prevent the spread of autoimmune diseases. Technological advancements in the medicals sector are also fueling the market’s growth. Between 2015 and 2023, the global autoimmune diseases diagnostics market is expected to exhibit a CAGR of 3.8%. The global autoimmune disease diagnostics market is likely to reach US$17.06 bn by 2023. The stiff price competition among players is expected to impact the growth of the market in a negative way.
North America to Continue to Lead in the Autoimmune Disease Diagnostics Market
By geography, North America is expected to lead in the autoimmune disease diagnostics market with the U.S. and Canada contributing the most to the market in the region. These countries have sophisticated healthcare infrastructure and laboratories with advanced techniques. There also exists high level of awareness regarding various medical procedures. The increased healthcare expenditure in the region will also be a contributing factor to the growth of the market in region. Asia Pacific is also expected to witness a rapid growth in the autoimmune disease diagnostics market on account of high demand from countries such as Malaysia, Australia, India, Japan, and China. Advancements in diagnostics devices will push the Asia Pacific autoimmune disease diagnostics market towards witnessing a CAGR of 4.3% between 2015 and 2023.
High Occurrence of Rheumatoid Arthritis to Drive Autoimmune Disease Diagnostics Market
Autoimmune diseases such as Graves’ disease, Hashimoto’s thyroiditis, multiple sclerosis, rheumatoid arthritis, systemic lupus erythematosus, and type1 diabetes are prevalent commonly. Of these, the most prevalent of all diseases is rheumatoid arthritis, which can occur to people falling under any age group. The rheumatoid arthritis segment is estimated to be worth US$4.6 bn by the end of 2022. The growing geriatric population and improved diagnosis of rheumatoid arthritis at improved laboratories will drive the segment towards growth in the coming year. Apart from rheumatoid arthritis, the type 1 diabetes segment is expected to show a healthy growth and exhibit a CAGR of 3.7% between 2015 and 2023.
Unavailability of Trained Professionals to Result in Operational Challenges
There is a dearth of trained professionals in the market which will hamper the growth of this market. In addition to this, a lack of automation will also pose a challenge and hamper the operations in clinical laboratories. Further, the threat of new entrants, mostly local players, will cause leading players to cut down their prices. Slashing down the prices of diagnostic devices so as to stay in the market and remain competitive is projected to have an adverse impact on the global autoimmune disease diagnostics market.
However, on the plus side, the market for autoimmune disease diagnostics is expected to find new opportunities for growth as leading players will leverage the untapped markets in emerging nations and capitalize on them. Players are also expected to concentrate on replacing traditional technologies with latest ones and automate the laboratories. This will help the market to grow. Additionally, the introduction of novel technologies will create promising growth for the market.
1.1. Report Description
1.2. Market Segmentation
1.3. Research Methodology
2. Executive Summary
2.1. Autoimmune Disease Diagnostics: Market Snapshot
2.2. Global Autoimmune Disease Diagnostics Market, by Test Type, 2014 (US$ Mn)
2.3. Global Autoimmune Disease Diagnostics Market Share, by Geography, 2014–2023 (US$ Mn)
3. Global Autoimmune Disease Diagnostics Market – Industry Analysis
3.2.1. High Prevalence of Autoimmune Diseases Across the World
3.2.2. Increased Health Care Expenditure Globally
3.2.3. Growing Awareness Among People About Autoimmune Diseases
3.3.1. Competitive Pricing and Equipment Costs
3.3.2. Shortage of Skilled Labor
3.4.1. Emerging Economies to Offer Sustained Growth Opportunities
3.4.2. New products, Services, and Device Development
3.5. Porter’s Five Forces Analysis
3.6. Market Attractiveness Analysis– Autoimmune Disease Diagnostics Market, by Geography, 2014 (%)
3.7. Competitive Landscape – Autoimmune Disease Diagnostics Market, by Key Players, 2014 (%)
4. Market Segmentation – By Test Type
4.2. Global Autoimmune Disease Diagnostics Market Revenue, 2013–2023 (US$ Mn)
4.3. Global Antinuclear Antibody Test Market Revenue, 2013–2023 (US$ Mn)
4.4. Global Autoantibody Test Market Revenue, 2013–2023 (US$ Mn)
4.5. Global Complete Blood Count Market Revenue, 2013–2023 (US$ Mn)
4.6. Global Comprehensive Metabolic Panel Market Revenue, 2013–2023 (US$ Mn)
4.7. Global C-reactive Protein Market Revenue, 2013–2023 (US$ Mn)
4.8. Global Erythrocyte Sedimentation Rate Market Revenue, 2013–2023 (US$ Mn)
4.9. Global Urinalysis Market Revenue, 2013–2023 (US$ Mn)
4.10. Global Other Tests Market Revenue, 2013–2023 (US$ Mn)
5. Market Segmentation – By Disease Type
5.2. Global Autoimmune Disease Diagnostics Market Revenue, 2013–2023 (US$ Mn)
5.3. Global Graves’ Disease Market Revenue, 2013–2023 (US$ Mn)
5.4. Global Hashimoto’s Thyroiditis Market Revenue, 2013–2023 (US$ Mn)
5.5. Global Multiple Sclerosis Market Revenue, 2013–2023 (US$ Mn)
5.6. Global Rheumatoid Arthritis Market Revenue, 2013–2023 (US$ Mn)
5.7. Global Systemic Lupus Erythematosus Market Revenue, 2013–2023 (US$ Mn)
5.8. Global Type 1 Diabetes Market Revenue, 2013–2023 (US$ Mn)
5.9. Global Other Diseases Market Revenue, 2013–2023 (US$ Mn)
6. Autoimmune Disease Diagnostics Market - Regional Analysis
6.2. Global Autoimmune Disease Diagnostics Market Revenue, 2013–2023 (US$ Mn)
6.3. North America Autoimmune Disease Diagnostics Market Revenue, 2013–2023 (US$ Mn)
6.4. Europe Autoimmune Disease Diagnostics Market Revenue, 2013–2023 (US$ Mn)
6.5. Asia Pacific Autoimmune Disease Diagnostics Market Revenue, 2013–2023 (US$ Mn)
6.6. RoW Autoimmune Disease Diagnostics Market Revenue, 2013–2023 (US$ Mn)
8. Company Profiles
8.1. Abbott Laboratories, Inc.
8.2. Beckman Coulter, Inc.
8.3. bioMérieux SA
8.4. Bio-Rad Laboratories
8.5. F.Hoffmann-La Roche Ltd.
8.6. Inova Diagnostics, Inc.
8.7. Quest Diagnostics
8.8. SQI Diagnostics, Inc.
8.9. Siemens Healthcare
This report on the autoimmune disease diagnostics market studies the current and future prospects of the global market. Autoimmune disease diagnostics market includes various laboratory tests that are performed to diagnose autoimmune disorders. These tests include blood tests for one or more autoantibodies and tests for inflammation. The rising prevalence of autoimmune diseases, increase in health care expenditure globally, rising government initiatives and increasing automation in laboratories leading to higher sensitivity, faster and easy performance will drive the market of autoimmune disease diagnostics. The autoimmune disease diagnostics market report comprises an elaborate executive summary, which includes a market snapshot that provides information about various segments and sub-segments of the market. It also provides information and data analysis of the global autoimmune disease diagnostics market with respect to market segments based on the test type and diseases and their geographic analysis.
Based on test type, the autoimmune disease diagnostics market has been segmented into eight major categories: antinuclear antibody test, autoantibody test, complete blood count, comprehensive metabolic panel, C-reactive protein test, erythrocyte sedimentation rate, urinalysis and others. On the basis of disease the autoimmune disease diagnostics market is categorized into seven segments namely: Graves’ disease, Hashimotos’s thyroiditis, rheumatoid arthritis, multiple sclerosis, type 1 diabetes, systemic lupus erythematosus and others. The market segments have been extensively analyzed based on usefulness, efficacy, revenue, and geographical coverage. The market size and forecast in terms of USD million for each segment has been provided for the period from 2013 to 2023. The report also provides the compound annual growth rate (CAGR %) for each market segment for the forecast period from 2015 to 2023, considering 2014 as the base year.
Geographically, autoimmune disease diagnostics market has been segmented into four major regions: North America, Europe, Asia-Pacific, and Rest of the World. The market size and forecast for each of these regions has been provided for the period from 2013 to 2023, along with their respective CAGRs for the forecast period from 2015 to 2023, considering 2014 as the base year. The research study also covers the competitive scenario in these regions. A detailed qualitative analysis of factors responsible for driving and restraining the growth of the market and future opportunities has been provided in the market overview section. This section of the report also provides market attractiveness analysis, Porter’s Five Forces analysis, and market share analysis by key players, thus presenting a thorough analysis of the overall competitive scenario in the global autoimmune disease diagnostics market.
A list of recommendations has been provided for new entrants as well as existing market players to assist them in taking strategic initiatives to establish a strong presence in the market. The report also profiles major players in the autoimmune disease diagnostics market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. Major players profiled in this report include Abbott Laboratories, Inc., Beckman Coulter, Inc., F. Hoffmann-La Roche Ltd., Bio- Rad laboratories, bioMerieux SA, Siemens Healthcare, Inova Diagnostics Inc., Quest Diagnostics and SQL Diagnostics, Inc.
The global autoimmune disease diagnostics market is segmented as follows:
Global Autoimmune Disease Diagnostics Market, by Test Type
- Antinuclear Antibody Tests
- Autoantibody Tests
- Complete Blood Count (CBC)
- Comprehensive Metabolic Panel
- C - reactive protein (CRP)
- Erythrocyte Sedimentation Rate (ESR)
Global Autoimmune Disease Diagnostics Market, by Disease Type
- Graves' Disease
- Hashimoto's Thyroiditis
- Multiple Sclerosis
- Rheumatoid Arthritis
- Systemic Lupus Erythematosus (lupus)
- Type 1 diabetes
Global Autoimmune Disease Diagnostics Market, by Geography
- North America
- Rest of Europe
- Asia Pacific
- Rest of Asia Pacific
- Rest of the World
- Latin America
- Middle East